Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 22, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,186	2,963	1,354	1,114	955	905
Market Cap Growth	5.13%	118.80%	21.52%	16.65%	5.51%	-1.30%
Enterprise Value	2,565	3,336	1,273	1,106	968	916
Last Close Price	45.46	61.85	28.02	23.29	20.11	19.29
PE Ratio	15.11	21.54	14.82	17.94	680.90	18.50
Forward PE	11.53	20.77	16.29	16.96	23.74	35.07
PS Ratio	3.04	4.60	2.71	2.55	2.73	2.81
PB Ratio	3.02	4.63	2.56	2.50	2.13	2.12
P/TBV Ratio	17.78	113.41	2.76	2.74	2.64	2.66
P/FCF Ratio	12.85	20.39	20.79	15.80	40.81	4374.08
P/OCF Ratio	10.50	16.15	15.19	11.37	16.68	21.68
PEG Ratio	1.21	1.06	0.86	0.89	0.95	1.40
EV/Sales Ratio	3.55	5.18	2.55	2.53	2.77	2.84
EV/EBITDA Ratio	9.62	14.03	9.63	11.65	27.85	50.72
EV/EBIT Ratio	11.97	16.70	11.85	15.43	73.07	-
EV/FCF Ratio	15.08	22.95	19.55	15.68	41.37	4427.46
Debt / Equity Ratio	0.87	0.98	0.19	0.23	0.15	0.16
Debt / EBITDA Ratio	2.31	2.56	0.75	1.05	1.69	2.94
Debt / FCF Ratio	3.70	4.29	1.57	1.48	2.87	321.86
Asset Turnover	0.47	0.57	0.71	0.67	0.57	0.59
Inventory Turnover	2.83	2.78	2.55	2.51	1.99	2.12
Quick Ratio	2.49	1.65	2.79	2.08	1.53	1.46
Current Ratio	3.43	2.17	3.99	3.06	2.49	2.84
Return on Equity (ROE)	23.85%	23.55%	18.76%	14.16%	0.25%	11.75%
Return on Assets (ROA)	8.67%	11.07%	9.51%	6.88%	1.36%	-0.00%
Return on Capital (ROIC)	10.20%	13.18%	11.37%	8.40%	1.64%	-0.01%
Earnings Yield	7.22%	4.64%	6.75%	5.57%	0.15%	5.41%
FCF Yield	7.78%	4.90%	4.81%	6.33%	2.45%	0.02%
Buyback Yield / Dilution	0.37%	-1.09%	-5.31%	-1.34%	1.57%	-7.57%
Total Shareholder Return	0.37%	-1.09%	-5.31%	-1.34%	1.57%	-7.57%

Source: S&P Capital IQ. Standard template. Financial Sources.